skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Products

Show More

Resources

Show More

Information Types

Show More

Roles

Show More

Show More

Product Listing

22 product(s) and free and sample content

From: RxScorecard

RxScorecard

​​Understand how payers make decisions and evaluate drugs against each other.

  • ​An evidence based payer supported web based tool
  • Clinical and economic metrics
  • Transparent scoring methodology

RxScorecard

Market Access Article Pack: Value Frameworks

28 Nov 2016

When it comes to value frameworks, one thing is certain, they’re here to stay.

Topic Reimbursement Deal trends

RxScorecard

Maximize your drugs market potential in a payer dominated world

23 Nov 2016

See how the value of drugs differentiate therapies by sub-population. Find out where the disproportionate value of your drug lies alongside competitors. Uncover demonstrable differentiated value when entering a crowded market. Discover the power of RxScorecard™.

Topic Reimbursement

From: Medtrack

Medtrack: full healthcare business coverage

From discovery to patent expiry, and coverage spanning both ethical and generic drugs, Medtrack has you covered. Stay current on key financing, drug and biologics development and drug manufacturing information, all with a single tool.

  • Find new opportunities
  • Forge new partnerships
  • Assess products and tech

Medtrack

Partnering in the Pharma world: BIO-Europe® and industry trends 2012-2015

By Patricia Giglio 14 Nov 2016

Partnering came into use twenty-odd years ago when pharmaceutical companies began working with biotech and increasingly sought external discovery and development opportunities.

Topic Clinical trial optimization

Medtrack

Maximizing Royalty Rate Opportunities in Pharma Licensing

By Steven Muntner 20 Oct 2016

Royalty payments are an essential component of most pharmaceutical deals. Along with upfront payments and milestones, companies are rewarded for surpassing certain developmental hurdles.

Topic Deal trends Medtech

From: Datamonitor Healthcare

Datamonitor Healthcare

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

  • Prioritize market opportunities
  • Identify unmet needs
  • Make informed decisions

Datamonitor Healthcare

Immuno-Oncology Overview

By Colin White, Robert Jeng & Jolene Lau 26 Oct 2016

This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well

Topic immuno-oncology

Datamonitor Healthcare

Profitability Assessment of Branded Generic Inhalers

By Ljlal Syed, Mark Lansdell and David Abramson 20 Oct 2016

This report examines the extent to which order of market entry influences the prospects of achieving a satisfactory return on investment for companies developing branded generic

Topic Deal trends

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:
Pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: